FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
CARB FENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARB FENCE
ST13
US500000079406956Class
5, 10
Filing
79406956
Registration
8097714
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 10
Filing date
06/25/2024
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
64
Owner location
SE
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Sigrid Therapeutics AB
Representatives
Bradley L. Cohn Pattishall, McAuliffe, Newbury, Hilliard
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietetic preparations adapted for medical use; dietetic food adapted for medical use; pharmaceutical preparations for use in naturopathy; nutritional supplements; pharmaceutical preparations for treating diabetes; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietetic preparations and food for glycemic control adapted for medical use; dietetic preparations and food for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substancesdietary and nutritional substancesmedicine in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of obesitybody weightbody fatbody compositionbody weight circumferencecholesterol and LDL cholesterol levelsliver diseasesteatohepatitisinfantile colicgut microbiotainsulin levels and resistanceblood lipidsdiarrheaconstipationcolitis; pharmaceutical preparations and substancesdietary and nutritional substancesmedicine in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of intestinal injury or inflammationCrohn's diseasecardiovascular risk factorspost bariatric surgery patients; dietetic substances in the nature of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions adapted for medical use; pharmaceutical preparations and natural remedy preparations for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; pharmaceutical preparations for use in naturopathy for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemical pharmaceutical preparations for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietetic preparations and food for glycemic control; dietetic preparations and food for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensions for use in the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substancesdietary and nutritional substances in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of obesitybody weightbody fatbody compositionbody weight circumferencecholesterol and LDL cholesterol levelsliver diseasesteatohepatitisinfantile colicgut microbiotainsulin levels and resistanceblood lipidsdiarrheaconstipationcolitis; pharmaceutical preparations and substancesdietary and nutritional substances in the form of tabletscapsulesliquid formulationsdrinksshotsshakesgelspowders and suspensionsall for use in the treatment and regulation of intestinal injury or inflammationCrohn's diseasecardiovascular risk factorspost bariatric surgery patients; dietary supplements for humans; dietary supplements for the support of healthy blood sugar levelsweight levelscholesterol levelsblood pressure levelsenergy levels; vitamin supplements; mineral supplements; food supplements; dietary and nutritional supplements for animals; nutritional additives to foodstuffs for animalsfor medical purposes in the nature of dietary supplements; vitamin supplements for animals; mineral dietary supplements for animals; antibiotic food supplements for animals; medicated supplements for foodstuffs for animals; pharmaceutical preparationsfoodnutritional supplements for animalsfor the prevention and treatment of prediabetesdiabetes and for the improvement of overall metabolic health; pharmaceutical preparationsfoodnutritional supplements for animalsfor weight lossweight managementprevention and treatment of obesity; pharmaceutical preparationsfood and nutritional supplements for animalsfor the treatment and regulation of body fatcholesterol and LDL cholesterol levelsblood lipids and gut microbiota; pharmaceutical preparations for use as additives to food for human consumption for medical purposes.
Class 10
Surgical and medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health and for use in weight control; capsulated medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health and for use in weight control; medical devices for treatment of prediabetesdiabetes and glycaemic controlfor the improvement of overall metabolic health and for use in weight control; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesitybeing overweightprediabetesdiabetesglycemic control and for the improvement of overall metabolic health and for use in weight control; surgical and medical devicescapsulated devices and orally administered medical devices all for use in the treatment and regulation of obesitybody weightbody fatbody compositionbody weight circumferencecholesterol and LDL cholesterol levelsliver disease; surgical and medical devicescapsulated devices and orally administered medical devices all for use in the treatment and regulation of steatohepatitisinfantile colicgut microbiotainsulin levels and resistanceblood lipidsdiarrheaconstipationintestinal injury or inflammationcolitisCrohn's diseasecardiovascular risk factorspost bariatric surgery patients
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2026
FIMP
FINAL DISPOSITION PROCESSED
07/18/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/13/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/16/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/16/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/02/2025
GNFR
FINAL REFUSAL E-MAILED
10/02/2025
CNFR
FINAL REFUSAL WRITTEN
10/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/18/2025
RFNT
REFUSAL PROCESSED BY IB
03/15/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/26/2025
RFRR
REFUSAL PROCESSED BY MPU
02/26/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2025
CNRT
NON-FINAL ACTION WRITTEN
01/10/2025
DOCK
ASSIGNED TO EXAMINER
12/23/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2024
Continuous trademark protection
Get notified about every new filing that threatens CARB FENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.